Skip to main content
. 2022 Jan 6;22:36. doi: 10.1186/s12879-021-07024-4

Table 2.

Outcomes in patients with Acinetobacter baumannii infections, stratified by carbapenem susceptibility status

Outcomes Overall
N = 5523
Carbapenem resistant
N = 2047
Carbapenem susceptible
N = 3476
P value
Overall LOSa
 Overall LOS, days, median (Q1–Q3) 10 (6.0–18.0) 11 (7.0–19.0) 9 (6.0–17.0)  < 0.01
Infection-associated LOSb
 Infection-associated LOS, days, median (Q1–Q3) 8 (5.0–14.0) 9 (5.0–14.0) 8 (5.0–13.0)  < 0.01
ICU utilization
 ICU admission during hospitalization, n (%) 2845 (51.5) 1276 (62.3) 1569 (45.1)  < 0.01
 Index culture during ICU stay, n (%) 2084 (37.7) 927 (45.3) 1157 (33.3)  < 0.01
 ICU-LOS, days, median (Q1–Q3)c 6 (2.0–15.0) 6 (3.0–14.0) 6 (2.0–15.0) 0.98
Infection-associated ICU utilization
 Index culture during infection-associated ICU stay, n (%) 2084 (37.7) 927 (45.3) 1157 (33.3)  < 0.01
 Infection-associated ICU-LOS, days, median (Q1–Q3)d 5 (2.0–10.0) 5 (2.0–10.0) 5 (2.0–10.0) 0.86
Discharge status, n (%)  < 0.01
 Death 683 (12.4) 336 (16.4) 347 (10.0)
 Home 1992 (36.1) 332 (16.2) 1660 (47.8)
 Hospice 236 (4.3) 98 (4.8) 138 (4.0)
 Other 92 (1.7) 14 (0.7) 78 (2.2)
 Transfer to other facility 2520 (45.6) 1267 (61.9) 1253 (36.1)

ICU intensive care unit, LOS length of stay

aDefined as the number of days from admission to discharge date, regardless of discharge status

bDefined as the number of days from index culture date to discharge, regardless of discharge status

cDefined as the number of days from first to the last ICU service day, regardless of discharge status

dDefined as the number of days in ICU that was associated with the infection (i.e., index culture was taken within 2 days before ICU admission or during the ICU stay) and calculated as the following: (1) if a positive culture was obtained within 2 days of ICU admission, the entire ICU. LOS was used; (2) if the culture was obtained during ICU stay, the LOS was taken as the number of days from the ICU index culture to discharge from the ICU